Cargando…

Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Previous studies have reported that glypican-4 (GPC4) regulates insulin signaling by interacting with insulin receptor and through adipocyte differentiation. However, GPC4 has not been studied with regard to its effects on clinical factors in patients with type 2 diabetes mellitus (T2DM)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang Ah, Koh, Gwanpyo, Cho, Suk Ju, Yoo, So-Yeon, Chin, Sang Ouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053057/ https://www.ncbi.nlm.nih.gov/pubmed/27704740 http://dx.doi.org/10.3803/EnM.2016.31.3.439

Ejemplares similares

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
por: Bang, Jisun, et al.
Publicado: (2023)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

Levels of glucagon-like peptide 1 in hyperemesis gravidarum
por: Aktulay, Ayla, et al.
Publicado: (2021)

Characteristics of Subjects with Very Low Serum Low-Density Lipoprotein Cholesterol and the Risk for Intracerebral Hemorrhage
por: Lee, Jae-Geun, et al.
Publicado: (2012)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

Glucagon−like Peptide−1 and−2 Levels in Children with Diabetic Ketoacidosis
por: Akıncı, Ayşehan, et al.
Publicado: (2009)

The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus
por: Lastya, Agus, et al.
Publicado: (2014)

Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients
por: Renner, Éva, et al.
Publicado: (2022)

Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes
por: Lim, Younghyup, et al.
Publicado: (2015)

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
por: Yoon, Hye-Jin, et al.
Publicado: (2012)

Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
por: Jeon, Yejoo, et al.
Publicado: (2016)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis
por: Singh, Sonal, et al.
Publicado: (2016)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Cho, Young Min, et al.
Publicado: (2013)

Effect of Jeju Water on Blood Glucose Levels in Diabetic Patients: A Randomized Controlled Trial
por: Koh, Gwanpyo, et al.
Publicado: (2013)

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017)

Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats
por: Bruzzone, Santina, et al.
Publicado: (2015)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
por: Ast, Julia, et al.
Publicado: (2023)

Postprandial Glucose, Insulin, and Glucagon-Like Peptide-1 Responses in Healthy Adults after Consumption of Chocolate-Products
por: Choi, Yunjung, et al.
Publicado: (2020)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Efficacy of once‐daily glucagon‐like peptide‐1 receptor agonist lixisenatide as an add‐on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual‐level pooled analysis of phase III studies
por: Liu, Fuqiang, et al.
Publicado: (2021)

Quetiapine-Induced Severe Hypoglycemia in Patient Without Diabetes Mellitus: A Case Report
por: Cho, Suk Ju, et al.
Publicado: (2019)

Arsenic Exposure and Prevalence of Diabetes Mellitus in Korean Adults
por: Rhee, Sang Youl, et al.
Publicado: (2013)

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification
por: Trautmann, M. E., et al.
Publicado: (2018)

Liraglutide Suppresses the Plasma Levels of Active and Des-Acyl Ghrelin Independently of Active Glucagon-Like Peptide-1 Levels in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2013)

Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis
por: Lugert, S., et al.
Publicado: (2017)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018)

Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis
por: Xie, Fei-Fei, et al.
Publicado: (2022)

Evaluation of Glucagon-like Peptide-1, Adropin, and Desnutrin Levels and Related Factors in Patients with Bipolar Disorder
por: Erşan, Serpil, et al.
Publicado: (2021)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_esaqnblhnt4kqd64vpa7907rhq